Acceleration of Hepatitis C Virus Envelope Evolution in Humans Is Consistent with Progressive Humoral Immune Selection during the Transition from Acute to Chronic Infection
暂无分享,去创建一个
Stuart C. Ray | S. Ray | Brian E. Fisher | Jacquie Astemborski | Kimberly A. Dowd | Andrea L. Cox | J. Astemborski | Lin Liu | Lin Liu | A. Cox
[1] Austin L. Hughes,et al. Extraepitopic Compensatory Substitutions Partially Restore Fitness to Simian Immunodeficiency Virus Variants That Escape from an Immunodominant Cytotoxic-T-Lymphocyte Response , 2004, Journal of Virology.
[2] K Y Liang,et al. Longitudinal data analysis for discrete and continuous outcomes. , 1986, Biometrics.
[3] O. Pybus,et al. Analysis of the Evolutionary Forces in an Immunodominant CD8 Epitope in Hepatitis C Virus at a Population Level , 2008, Journal of Virology.
[4] F. Chisari,et al. Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection , 2001, The Journal of experimental medicine.
[5] J. Sidney,et al. High-Programmed Death-1 Levels on Hepatitis C Virus-Specific T Cells during Acute Infection Are Associated with Viral Persistence and Require Preservation of Cognate Antigen during Chronic Infection1 , 2008, The Journal of Immunology.
[6] John Sidney,et al. Reversion of CTL escape–variant immunodeficiency viruses in vivo , 2004, Nature Medicine.
[7] B. Bell,et al. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. , 2006, Journal of hepatology.
[8] P. Klenerman,et al. CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained , 2000, European journal of immunology.
[9] S. Ray,et al. Selection pressure from neutralizing antibodies drives sequence evolution during acute infection with hepatitis C virus. , 2009, Gastroenterology.
[10] Katrina Walsh,et al. Rapid Viral Escape at an Immunodominant Simian-Human Immunodeficiency Virus Cytotoxic T-Lymphocyte Epitope Exacts a Dramatic Fitness Cost , 2005, Journal of Virology.
[11] Chen Liu,et al. An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection , 2004, Hepatology.
[12] Gary D. Stormo,et al. Displaying the information contents of structural RNA alignments: the structure logos , 1997, Comput. Appl. Biosci..
[13] M. Tong,et al. Clinical outcomes after transfusion-associated hepatitis C. , 1995, The New England journal of medicine.
[14] S. Ray,et al. Progression of Fibrosis during Chronic Hepatitis C Is Associated with Rapid Virus Evolution , 2007, Journal of Virology.
[15] Stuart C. Ray,et al. Divergent and convergent evolution after a common-source outbreak of hepatitis C virus , 2005, The Journal of experimental medicine.
[16] M. Shapiro,et al. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[17] L. P. Zhao,et al. HIV Quasispecies and Resampling , 1996, Science.
[18] R. Purcell,et al. Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain , 2008, Journal of Virology.
[19] Toshiaki Maruyama,et al. Complete Replication of Hepatitis C Virus in Cell Culture , 2005, Science.
[20] E L Murphy,et al. Prevalence of hepatitis C virus infection in the United States. , 1999, The New England journal of medicine.
[21] J. McKeating,et al. Hepatitis C virus cell‐cell transmission in hepatoma cells in the presence of neutralizing antibodies , 2007, Hepatology.
[22] J. Sidney,et al. Cellular immune selection with hepatitis C virus persistence in humans , 2005, The Journal of experimental medicine.
[23] David Posada,et al. MODELTEST: testing the model of DNA substitution , 1998, Bioinform..
[24] C. Cheng‐Mayer,et al. Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[25] T. Wright,et al. Acute hepatitis C , 2001, Hepatology.
[26] C. Rice,et al. Hepatitis C virus continuously escapes from neutralizing antibody and T-cell responses during chronic infection in vivo. , 2007, Gastroenterology.
[27] H J Alter,et al. The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. , 2000, Science.
[28] R. Lanford,et al. Viral Persistence, Antibody to E1 and E2, and Hypervariable Region 1 Sequence Stability in Hepatitis C Virus-Inoculated Chimpanzees , 1999, Journal of Virology.
[29] O. Laeyendecker,et al. Hypervariable Region 1 Sequence Stability during Hepatitis C Virus Replication in Chimpanzees , 2000, Journal of Virology.
[30] D. Vlahov,et al. Determinants of the quantity of hepatitis C virus RNA. , 2000, The Journal of infectious diseases.
[31] K. Reddy,et al. Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 T-cell responses in acute hepatitis C. , 2007, Gastroenterology.
[32] D. Vlahov,et al. Persistence of viremia and the importance of long‐term follow‐up after acute hepatitis C infection , 1999, Hepatology.
[33] Tara L. Kieffer,et al. Dynamic hepatitis C virus genotypic and phenotypic changes in patients treated with the protease inhibitor telaprevir. , 2007, Gastroenterology.
[34] Inda,et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. , 1999, The New England journal of medicine.
[35] R. Purcell,et al. Genetic Heterogeneity of Hepatitis C Virus: Quasispecies and Genotypes , 1995, Seminars in liver disease.
[36] B. Bartosch,et al. Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1–E2 Envelope Protein Complexes , 2003, The Journal of experimental medicine.
[37] Alan S. Perelson,et al. The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection , 2009, The Journal of experimental medicine.
[38] G. Lauer,et al. Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C , 2005, Hepatology.
[39] Hepatitis C: global prevalence. , 1997, Releve epidemiologique hebdomadaire.
[40] D. Burton,et al. Robust hepatitis C virus infection in vitro. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[41] C. Rice,et al. Mutations in Hepatitis C Virus E2 Located outside the CD81 Binding Sites Lead to Escape from Broadly Neutralizing Antibodies but Compromise Virus Infectivity , 2009, Journal of Virology.
[42] R. Bartenschlager,et al. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome , 2005, Nature Medicine.
[43] D. Nickle,et al. Consensus and Ancestral State HIV Vaccines , 2003, Science.
[44] O. Laeyendecker,et al. Accurate Representation of the Hepatitis C Virus Quasispecies in 5.2-Kilobase Amplicons , 2004, Journal of Clinical Microbiology.
[45] Alessandro Sette,et al. Selection, Transmission, and Reversion of an Antigen-Processing Cytotoxic T-Lymphocyte Escape Mutation in Human Immunodeficiency Virus Type 1 Infection , 2004, Journal of Virology.
[46] Todd M. Allen,et al. Viral Sequence Evolution in Acute Hepatitis C Virus Infection , 2007, Journal of Virology.
[47] Alan S. Perelson,et al. Hepatitis C Viral Dynamics in Vivo and the Antiviral Efficacy of Interferon-α Therapy , 1998 .
[48] A. Weiner,et al. Hepatitis C virus (HCV) circulates as a population of different but closely related genomes: quasispecies nature of HCV genome distribution , 1992, Journal of virology.
[49] L. Seeff,et al. Aasld Practice Guideline Diagnosis, Management, and Treatment of Hepatitis C , 2003 .
[50] B. Walker,et al. Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus , 2000, The Journal of experimental medicine.
[51] S. Ray,et al. Humoral immune response in acute hepatitis C virus infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] P. Schürmann,et al. Rapid induction of virus-neutralizing antibodies and viral clearance in a single-source outbreak of hepatitis C , 2007, Proceedings of the National Academy of Sciences.
[53] P. Klenerman,et al. Escape from HLA-B*08-Restricted CD8 T Cells by Hepatitis C Virus Is Associated with Fitness Costs , 2008, Journal of Virology.
[54] D. Vlahov,et al. Prospective evaluation of community-acquired acute-phase hepatitis C virus infection. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[55] Todd M. Allen,et al. HIV evolution: CTL escape mutation and reversion after transmission , 2004, Nature Medicine.
[56] C. Rice,et al. Neutralizing antibody response during acute and chronic hepatitis C virus infection. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[57] Todd M. Allen,et al. CD8 Epitope Escape and Reversion in Acute HCV Infection , 2004, The Journal of experimental medicine.
[58] Todd M. Allen,et al. Impaired Hepatitis C Virus-Specific T Cell Responses and Recurrent Hepatitis C Virus in HIV Coinfection , 2006, PLoS medicine.
[59] Christos J. Petropoulos,et al. Constraints on HIV-1 evolution and immunodominance revealed in monozygotic adult twins infected with the same virus , 2006, The Journal of experimental medicine.
[60] H. Thomas,et al. Comparison of the rate of sequence variation in the hypervariable region of E2/NS1 region of hepatitis C virus in normal and hypogammaglobulinemic patients , 1998, Hepatology.
[61] J. McKeating,et al. Hepatitis C virus entry and neutralization. , 2008, Clinics in liver disease.
[62] A S Perelson,et al. Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. , 1998, Science.